Coverage of "MRNA vaccine" on Cryptopasta: the stories and the context behind them.
FDA approval of Moderna's mFLUSIVA flu vaccine for older adults pushed shares up 3.37% pre-market, adding a fourth U.S. product to the company's respiratory vaccine portfolio ahead of a 2026-2027 launch.
August 6, 2026
